Minerva Surgical, Inc. (NasdaqGM:UTRS) acquired Certain Assets of Boston Scientific Corporation (NYSE:BSX) in May 2020. As partial consideration for BSC's assets, $15.0 million and issued BSC 1,331,411 shares of our Series D redeemable convertible preferred stock. Deferred payment of $15.0 million and a $10 million payment to satisfy the Development Milestone and $5 million to satisfy the first Revenue Milestone payment.

Minerva Surgical, Inc. (NasdaqGM:UTRS) completed the acquisition of Certain Assets of Boston Scientific Corporation (NYSE:BSX) in May 2020.